Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Arrhythmias

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    September 2019
  1. YAKABE D, Aso A, Araki M, Murasato Y, et al
    Efficacy of hybrid therapy using prior administration of bepridil hydrochloride and cryoballoon ablation in patients with persistent atrial fibrillation.
    J Cardiol. 2019 Sep 17. pii: S0914-5087(19)30278.
    PubMed     Text format     Abstract available


  2. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    PubMed     Text format     Abstract available


  3. OKA T, Tanaka K, Ninomiya Y, Hirao Y, et al
    Impact of baseline left atrial function on long-term outcome after catheter ablation for paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 11. pii: S0914-5087(19)30275.
    PubMed     Text format     Abstract available


  4. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Text format     Abstract available


    August 2019
  5. CHEN M, Wang Q, Sun J, Zhang PP, et al
    Early repolarization in the inferior leads after accessory pathway ablation is highly correlated with atrial fibrillation in Wolff-Parkinson-White syndrome.
    J Cardiol. 2019 Aug 21. pii: S0914-5087(19)30243.
    PubMed     Text format     Abstract available


  6. INOUE H, Umeyama M, Yamada T, Hashimoto H, et al
    Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study.
    J Cardiol. 2019 Aug 14. pii: S0914-5087(19)30223.
    PubMed     Text format     Abstract available


    July 2019
  7. NAKAGAWARA J, Ikeda T, Ogawa S, Kitazono T, et al
    Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function.
    J Cardiol. 2019 Jul 29. pii: S0914-5087(19)30173.
    PubMed     Text format     Abstract available


  8. OKUMURA Y, Nagashima K
    Innocent bystander or criminal? Influence of respiratory dysfunction on risk of atrial fibrillation.
    J Cardiol. 2019 Jul 25. pii: S0914-5087(19)30205.
    PubMed     Text format    


  9. SAKAMOTO Y, Nishiyama Y, Iwasaki YK, Daida H, et al
    Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study.
    J Cardiol. 2019 Jul 20. pii: S0914-5087(19)30172.
    PubMed     Text format     Abstract available


  10. INOUE K, Hirao K, Aonuma K, Kumagai K, et al
    HAS-BLED score as a predictor of bleeding complications from catheter ablation of atrial fibrillation: A subanalysis of the Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registries.
    J Cardiol. 2019 Jul 18. pii: S0914-5087(19)30177.
    PubMed     Text format     Abstract available


  11. KOMAL S, Yin JJ, Wang SH, Huang CZ, et al
    MicroRNAs: Emerging biomarkers for atrial fibrillation.
    J Cardiol. 2019 Jul 16. pii: S0914-5087(19)30204.
    PubMed     Text format     Abstract available


    June 2019
  12. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    Efficacy of cryoablation for paroxysmal and persistent atrial fibrillation in patients with structural heart disease.
    J Cardiol. 2019 Jun 27. pii: S0914-5087(19)30165.
    PubMed     Text format    


  13. YAMASHITA T, Nakasu Y, Mizutani H, Sumitani K, et al
    A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    J Cardiol. 2019 Jun 26. pii: S0914-5087(19)30153.
    PubMed     Text format     Abstract available


  14. YOSHIGA Y, Okamoto T, Shimizu A, Ueyama T, et al
    Correlation between asymptomatic gastroesophageal excessive transmural injury after pulmonary vein isolation and a bonus freeze protocol using the second-generation 28-mm cryoballoon for paroxysmal atrial fibrillation.
    J Cardiol. 2019 Jun 26. pii: S0914-5087(19)30147.
    PubMed     Text format     Abstract available


  15. KIM BS, Park JK, Lee Y, Shin JH, et al
    The relationship between decreased pulmonary function and atrial fibrillation in general population: Findings from Ansung-Ansan cohort of the Korean Genome and Epidemiology Study.
    J Cardiol. 2019 Jun 25. pii: S0914-5087(19)30155.
    PubMed     Text format     Abstract available


    May 2019
  16. YANG M, Zhang S, Liang J, Tang Y, et al
    Different effects of norepinephrine and nerve growth factor on atrial fibrillation vulnerability.
    J Cardiol. 2019 May 15. pii: S0914-5087(19)30117.
    PubMed     Text format     Abstract available


  17. GOURRONC Y, Grall S, Ingremeau D, Desprets L, et al
    De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry.
    J Cardiol. 2019 May 9. pii: S0914-5087(19)30040.
    PubMed     Text format     Abstract available


  18. NAKASHIMA A, Miyoshi T, Aoki-Kamiya C, Nishio M, et al
    Predicting postpartum cardiac events in pregnant women with complete atrioventricular block.
    J Cardiol. 2019 May 3. pii: S0914-5087(19)30099.
    PubMed     Text format     Abstract available


    April 2019
  19. NAKAMURA R, Okishige K, Shigeta T, Nishimura T, et al
    Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
    J Cardiol. 2019 Apr 24. pii: S0914-5087(19)30039.
    PubMed     Text format     Abstract available


  20. UETAKE S, Maruyama M, Mitsuishi T, Takahashi K, et al
    Diastolic wall strain predicts progression from paroxysmal to persistent or permanent atrial fibrillation in structurally normal hearts.
    J Cardiol. 2019 Apr 20. pii: S0914-5087(19)30096.
    PubMed     Text format     Abstract available


  21. FERRI-CERTIC J, Zavrl-Dzananovic D, Lezaic L, Zizek D, et al
    Impact of left ventricular pacing threshold on ventricular arrhythmia occurrence in cardiac resynchronization therapy.
    J Cardiol. 2019 Apr 13. pii: S0914-5087(19)30087.
    PubMed     Text format     Abstract available


    March 2019
  22. MACHINO-OHTSUKA T, Seo Y, Ishizu T, Yamamoto M, et al
    Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    J Cardiol. 2019 Mar 22. pii: S0914-5087(19)30057.
    PubMed     Text format     Abstract available


  23. YAMAGUCHI T, Nozato T, Miwa N, Sagawa Y, et al
    Impact of the preprocedural nutrition status on the clinical outcomes of patients after pacemaker implantation for bradycardia.
    J Cardiol. 2019 Mar 14. pii: S0914-5087(19)30050.
    PubMed     Text format     Abstract available


  24. LYAN E, Yalin K, Abdin A, Sawan N, et al
    Mechanism, underlying substrate and predictors of atrial tachycardia following atrial fibrillation ablation using the second-generation cryoballoon.
    J Cardiol. 2019 Mar 13. pii: S0914-5087(19)30042.
    PubMed     Text format     Abstract available


  25. INOUE H, Uchiyama S, Atarashi H, Okumura K, et al
    Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-Dabigatran Surveillance.
    J Cardiol. 2019 Mar 11. pii: S0914-5087(19)30044.
    PubMed     Text format     Abstract available


  26. DOHI T, Nakatani D, Inoue K, Hikoso S, et al
    Effect of Extensive Ablation on Recurrence in Patients with Persistent Atrial Fibrillation Treated with Pulmonary Vein Isolation (EARNEST-PVI) trial: Design and rationale.
    J Cardiol. 2019 Mar 7. pii: S0914-5087(19)30016.
    PubMed     Text format     Abstract available


  27. KIM JO, Shim J, Lee SH, Yu HT, et al
    Clinical characteristics and rhythm outcome of catheter ablation of hemodynamically corrected valvular atrial fibrillation.
    J Cardiol. 2019 Mar 5. pii: S0914-5087(18)30361.
    PubMed     Text format     Abstract available


    February 2019
  28. GOYA M
    Light and shadows of atrial fibrillation ablation using a cryoballoon.
    J Cardiol. 2019 Feb 28. pii: S0914-5087(19)30007.
    PubMed     Text format    


  29. KIM IS, Kim HJ, Yu HT, Kim TH, et al
    Non-vitamin K antagonist oral anticoagulants with amiodarone, P-glycoprotein inhibitors, or polypharmacy in patients with atrial fibrillation: Systematic review and meta-analysis.
    J Cardiol. 2019 Feb 12. pii: S0914-5087(19)30001.
    PubMed     Text format     Abstract available


  30. IKEDA T, Ogawa S, Kitazono T, Nakagawara J, et al
    Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).
    J Cardiol. 2019 Feb 7. pii: S0914-5087(19)30003.
    PubMed     Text format     Abstract available


  31. INOUE H, Uchiyama S, Atarashi H, Okumura K, et al
    Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance.
    J Cardiol. 2019 Feb 5. pii: S0914-5087(18)30366.
    PubMed     Text format     Abstract available


    January 2019
  32. PRADELLA M, Sticherling C, Spies F, Reichlin T, et al
    Burden-based classification of atrial fibrillation predicts multiple-procedure success of pulmonary vein isolation.
    J Cardiol. 2019 Jan 30. pii: S0914-5087(19)30002.
    PubMed     Text format     Abstract available


  33. SHI Y, Yin J, Hu H, Xue M, et al
    Targeted regulation of sympathetic activity in paraventricular nucleus reduces inducible ventricular arrhythmias in rats after myocardial infarction.
    J Cardiol. 2019;73:81-88.
    PubMed     Text format     Abstract available


  34. ONO T, Ikemura N, Kimura T, Ueda I, et al
    Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter outpatient registry.
    J Cardiol. 2019;73:14-21.
    PubMed     Text format     Abstract available


    December 2018
  35. WU CI, Chang SL, Lin CY, Vicera JJB, et al
    Clinical significance of J wave in prediction of ventricular arrhythmia in patients with acute myocardial infarction.
    J Cardiol. 2018 Dec 27. pii: S0914-5087(18)30330.
    PubMed     Text format     Abstract available


  36. KURONUMA K, Okumura Y, Yokoyama K, Matsumoto N, et al
    Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: A SAKURA AF Registry substudy.
    J Cardiol. 2018 Dec 24. pii: S0914-5087(18)30333.
    PubMed     Text format     Abstract available


  37. WU J, Sakaguchi T, Takenaka K, Toyoda F, et al
    A trafficking-deficient KCNQ1 mutation, T587M, causes a severe phenotype of long QT syndrome by interfering with intracellular hERG transport.
    J Cardiol. 2018 Dec 24. pii: S0914-5087(18)30358.
    PubMed     Text format     Abstract available


  38. YAMASHITA T, Ikeda T, Akita Y
    Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    J Cardiol. 2018 Dec 24. pii: S0914-5087(18)30336.
    PubMed     Text format     Abstract available


  39. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Impact of stroke volume on prognostic outcome in patients with atrial fibrillation and concomitant heart failure with preserved ejection fraction.
    J Cardiol. 2018 Dec 22. pii: S0914-5087(18)30354.
    PubMed     Text format     Abstract available


  40. CHEN S, Julian Chun KR, Bordignon S, Weise FK, et al
    Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    J Cardiol. 2018 Dec 21. pii: S0914-5087(18)30357.
    PubMed     Text format     Abstract available


  41. ISO K, Watanabe I, Okumura Y, Nagashima K, et al
    No association between dormant conduction sites and pulmonary vein reconnection sites in late atrial fibrillation recurrence after catheter ablation.
    J Cardiol. 2018;72:488-493.
    PubMed     Text format     Abstract available


    November 2018
  42. KORETSUNE Y, Yamashita T, Yasaka M, Ono Y, et al
    Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
    J Cardiol. 2018 Nov 23. pii: S0914-5087(18)30293.
    PubMed     Text format     Abstract available


    October 2018
  43. SAITO Y, Kobayashi Y
    Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    J Cardiol. 2018 Oct 4. pii: S0914-5087(18)30247.
    PubMed     Text format     Abstract available


    August 2018
  44. FUKAMACHI D, Hirayama A, Miyauchi K, Yasuda S, et al
    Corrigendum to "Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology" [J. Cardiol. 72 (2) (2018) 113-1
    J Cardiol. 2018 Aug 7. pii: S0914-5087(18)30208.
    PubMed     Text format    


    July 2018
  45. HAMADA R, Muto S
    Simple risk model and score for predicting of incident atrial fibrillation in Japanese.
    J Cardiol. 2018 Jul 28. pii: S0914-5087(18)30198.
    PubMed     Text format     Abstract available


    June 2018
  46. ITO M, Yamabe H, Koyama J, Kanazawa H, et al
    Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.
    J Cardiol. 2018 Jun 20. pii: S0914-5087(18)30144.
    PubMed     Text format     Abstract available


  47. SHINOHARA M, Fujino T, Yao S, Yano K, et al
    Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation.
    J Cardiol. 2018 Jun 10. pii: S0914-5087(18)30147.
    PubMed     Text format     Abstract available


    May 2018
  48. SANNA GD, Gabrielli E, De Vito E, Nusdeo G, et al
    Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era.
    J Cardiol. 2018 May 28. pii: S0914-5087(18)30123.
    PubMed     Text format     Abstract available


  49. YAMAGUCHI T, Tsuchiya T, Fukui A, Kawano Y, et al
    Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation.
    J Cardiol. 2018 May 25. pii: S0914-5087(18)30122.
    PubMed     Text format     Abstract available


  50. LEE SH, Jeong MH, Kim JH, Kim MC, et al
    A new risk score for ventricular tachyarrhythmia in acute myocardial infarction with preserved left ventricular ejection fraction.
    J Cardiol. 2018 May 17. pii: S0914-5087(18)30119.
    PubMed     Text format     Abstract available


  51. BOUREZG A, Bochaton T, Mewton N, Morel O, et al
    Atrial fibrillation, intra-ventricular thrombus, and other anticoagulant indications relationship with adverse outcomes in acute anterior myocardial infarction patients.
    J Cardiol. 2018 May 9. pii: S0914-5087(18)30092.
    PubMed     Text format     Abstract available


  52. SAITO C, Minami Y, Arai K, Haruki S, et al
    Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation.
    J Cardiol. 2018 May 8. pii: S0914-5087(18)30108.
    PubMed     Text format     Abstract available


    April 2018
  53. KIM IS, Kim HJ, Kim TH, Uhm JS, et al
    Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    J Cardiol. 2018 Apr 26. pii: S0914-5087(18)30093.
    PubMed     Text format     Abstract available


  54. GOYA M, Nagashima M, Hiroshima KI, Hayashi K, et al
    Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    J Cardiol. 2018 Apr 25. pii: S0914-5087(18)30091.
    PubMed     Text format     Abstract available


  55. ANDO SI
    Influence of hypoxia induced by sleep disordered breathing in case of hypertension and atrial fibrillation.
    J Cardiol. 2018 Apr 4. pii: S0914-5087(18)30076.
    PubMed     Text format     Abstract available


  56. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.
    J Cardiol. 2018 Apr 3. pii: S0914-5087(18)30078.
    PubMed     Text format     Abstract available


    March 2018
  57. ICHIJO S, Miyazaki S, Kusa S, Nakamura H, et al
    Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    J Cardiol. 2018 Mar 30. pii: S0914-5087(18)30063.
    PubMed     Text format     Abstract available


  58. TOMITA H, Sasaki S, Hagii J, Metoki N, et al
    Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    J Cardiol. 2018 Mar 30. pii: S0914-5087(18)30075.
    PubMed     Text format     Abstract available


  59. FUKAMACHI D, Hirayama A, Miyauchi K, Yasuda S, et al
    Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    J Cardiol. 2018 Mar 26. pii: S0914-5087(18)30054.
    PubMed     Text format     Abstract available


  60. STIEGER P, Rana OR, Saygili E, Zazai H, et al
    Impact of internal and external electrical cardioversion on cardiac specific enzymes and inflammation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2018 Mar 12. pii: S0914-5087(18)30048.
    PubMed     Text format     Abstract available


  61. KIM IS, Kim HJ, Kim TH, Uhm JS, et al
    Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2018 Mar 5. pii: S0914-5087(18)30047.
    PubMed     Text format     Abstract available


  62. MIYAZAKI S, Miyauchi K, Hayashi H, Tanaka R, et al
    Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics.
    J Cardiol. 2018 Mar 1. pii: S0914-5087(17)30316.
    PubMed     Text format     Abstract available


    February 2018
  63. OKISHIGE K, Aoyagi H, Nishimura T, Shigeta T, et al
    Characteristics of dormant pulmonary vein conduction induced by adenosine triphosphate in patients with atrial fibrillation undergoing cryoballoon ablation.
    J Cardiol. 2018 Feb 26. pii: S0914-5087(17)30329.
    PubMed     Text format     Abstract available


  64. YOSHIGA Y, Shimizu A, Ueyama T, Ono M, et al
    Strict sequential catheter ablation strategy targeting the pulmonary veins and superior vena cava for persistent atrial fibrillation.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30016.
    PubMed     Text format     Abstract available


  65. SPARTALIS M, Voudris V, Iliopoulos DC, Spartalis E, et al
    The paradox of increased risk of atrial fibrillation following bariatric surgery.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30015.
    PubMed     Text format    


  66. ARAI R, Suzuki S, Semba H, Arita T, et al
    The predictive role of E/e' on ischemic stroke and atrial fibrillation in Japanese patients without atrial fibrillation.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30013.
    PubMed     Text format     Abstract available


  67. YAGI N, Itoh H, Hisamatsu T, Tomita Y, et al
    A challenge for mutation specific risk stratification in long QT syndrome type 1.
    J Cardiol. 2018 Feb 10. pii: S0914-5087(18)30012.
    PubMed     Text format     Abstract available


    January 2018
  68. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
    J Cardiol. 2018 Jan 18. pii: S0914-5087(18)30003.
    PubMed     Text format     Abstract available


  69. YAMAGUCHI T, Shimakawa Y, Mitsumizo S, Fukui A, et al
    Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation.
    J Cardiol. 2018 Jan 12. pii: S0914-5087(18)30001.
    PubMed     Text format     Abstract available


  70. KUMOR M, Lipczynska M, Biernacka EK, Klisiewicz A, et al
    Cardiac arrest and ventricular arrhythmia in adults with Ebstein anomaly and left ventricular non-compaction.
    J Cardiol. 2018 Jan 2. pii: S0914-5087(17)30342.
    PubMed     Text format     Abstract available


  71. MARZAHN C, Koban C, Seifert M, Isotani A, et al
    Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation.
    J Cardiol. 2018;71:101-108.
    PubMed     Text format     Abstract available


    December 2017
  72. KAWAMOTO N, Fujita T, Fukushima S, Shimahara Y, et al
    Late onset of atrial fibrillation in patients undergoing mitral valve repair for type II dysfunction.
    J Cardiol. 2017 Dec 21. pii: S0914-5087(17)30340.
    PubMed     Text format     Abstract available


    November 2017
  73. KONDO Y, Senoo K, Kobayashi Y
    Direct oral anticoagulants for Japanese atrial fibrillation in the elderly.
    J Cardiol. 2017 Nov 16. pii: S0914-5087(17)30279.
    PubMed     Text format    


  74. FUKUMOTO D, Ding WG, Wada Y, Fujii Y, et al
    Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    J Cardiol. 2017 Nov 13. pii: S0914-5087(17)30273.
    PubMed     Text format     Abstract available


  75. HAMADA R, Lee JS, Mori K, Watanabe E, et al
    Influence of abdominal obesity and habitual behaviors on incident atrial fibrillation in Japanese.
    J Cardiol. 2017 Nov 7. pii: S0914-5087(17)30201.
    PubMed     Text format     Abstract available


    October 2017
  76. SWISSA M, Birk E, Dagan T, Abby Naimer S, et al
    Limited fluoroscopy catheter ablation of accessory pathways in children.
    J Cardiol. 2017;70:382-386.
    PubMed     Text format     Abstract available


  77. HARTL S, Dorwarth U, Bunz B, Wankerl M, et al
    Lessons from individualized cryoballoon sizing. Is there a role for the small balloon?
    J Cardiol. 2017;70:374-381.
    PubMed     Text format     Abstract available


    September 2017
  78. BANDO S, Nishikado A, Hiura N, Ikeda S, et al
    Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT).
    J Cardiol. 2017 Sep 29. pii: S0914-5087(17)30237.
    PubMed     Text format     Abstract available


  79. RHYOU HI, Park TH, Cho YR, Park K, et al
    Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI.
    J Cardiol. 2017 Sep 29. pii: S0914-5087(17)30236.
    PubMed     Text format     Abstract available


  80. WATANABE I
    Smoking and risk of atrial fibrillation.
    J Cardiol. 2017 Sep 13. pii: S0914-5087(17)30217.
    PubMed     Text format     Abstract available


  81. IMTIAZ AHMAD M, Mosley CD, O'Neal WT, Judd SE, et al
    Smoking and risk of atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    J Cardiol. 2017 Sep 5. pii: S0914-5087(17)30214.
    PubMed     Text format     Abstract available


  82. YAMABE H, Kaikita K, Matsumura T, Iwasa A, et al
    Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    J Cardiol. 2017 Sep 5. pii: S0914-5087(17)30210.
    PubMed     Text format     Abstract available


  83. SHINOHARA M, Fujino T, Koike H, Kitahara K, et al
    Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    J Cardiol. 2017;70:212-219.
    PubMed     Text format     Abstract available


    August 2017
  84. SHINGU Y, Yokota T, Takada S, Niwano H, et al
    Decreased gene expression of fatty acid binding protein 3 in the atrium of patients with new onset of atrial fibrillation in cardiac perioperative phase.
    J Cardiol. 2017 Aug 11. pii: S0914-5087(17)30193.
    PubMed     Text format     Abstract available


    July 2017
  85. KANDA T, Masuda M, Fujita M, Iida O, et al
    Comparison of the origin and coupling interval between ectopy with and without atrial fibrillation initiation.
    J Cardiol. 2017 Jul 13. pii: S0914-5087(17)30162.
    PubMed     Text format     Abstract available


    June 2017
  86. SAWAMURA A, Okumura T, Hiraiwa H, Aoki S, et al
    Cholesterol metabolism as a prognostic marker in patients with mildly symptomatic nonischemic dilated cardiomyopathy.
    J Cardiol. 2017;69:888-894.
    PubMed     Text format     Abstract available


    May 2017
  87. ITO K, Abe Y, Takahashi Y, Shimada Y, et al
    Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: A study using three-dimensional transesophageal echocardiography.
    J Cardiol. 2017 May 17. pii: S0914-5087(17)30101.
    PubMed     Text format     Abstract available


  88. DEL CAMPO A, Roldan J, Verdejo HE, Zalaquett R, et al
    Increased C-reactive protein plasma levels are not involved in the onset of post-operative atrial fibrillation.
    J Cardiol. 2017 May 12. pii: S0914-5087(17)30099.
    PubMed     Text format     Abstract available


    March 2017
  89. ALONSO A, Lutsey PL, Chen LY, MacLehose RF, et al
    Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.
    J Cardiol. 2017 Mar 17. pii: S0914-5087(17)30029.
    PubMed     Text format    


  90. WANG CH, Cheng ML, Liu MH, Kuo LT, et al
    Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    J Cardiol. 2017 Mar 16. pii: S0914-5087(16)30244.
    PubMed     Text format     Abstract available


    February 2017
  91. WEGNER FK, Silvano M, Bogeholz N, Leitz PR, et al
    Slow pathway modification in patients presenting with only two consecutive AV nodal echo beats.
    J Cardiol. 2017;69:471-475.
    PubMed     Text format     Abstract available


  92. SUGANO A, Seo Y, Yamamoto M, Harimura Y, et al
    Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    J Cardiol. 2017;69:456-461.
    PubMed     Text format     Abstract available


    January 2017
  93. POTT A, Messemer M, Petscher K, Iturbe-Orbe M, et al
    Clinical outcome of 2nd generation cryoballoon pulmonary vein isolation in patients over 75 years of age.
    J Cardiol. 2017;69:24-29.
    PubMed     Text format     Abstract available


  94. SASAKI S, Shoji Y, Ishida Y, Kinjo T, et al
    Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    J Cardiol. 2017;69:359-363.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: